MicroRNA biosensors for the detection of intestinal diseases

Asma Vafadar1, Sajad Alavimanesh2, Melika Eghtesadi1

  • 1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.

Insights

MicroRNAs (miRNAs) are key in intestinal diseases. Electrochemical biosensors offer a promising, sensitive method for early detection and monitoring of these conditions, improving patient outcomes.

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Gastroenterology

Background:

  • Intestinal disorders like colorectal cancer, Crohn's disease, and ulcerative colitis pose significant health challenges due to complex pathogenesis and delayed diagnosis.
  • MicroRNAs (miRNAs) are critical regulators of cellular functions involved in intestinal health and disease, with abnormal expression linked to disease onset and progression.

Purpose of the Study:

  • To review the potential of miRNA-based electrochemical biosensors for early detection and monitoring of intestinal diseases.
  • To analyze the role of miRNAs in the pathogenesis of intestinal disorders.
  • To highlight advancements in electrochemical biosensor development for miRNA detection in these conditions.

Main Methods:

  • Review of current literature on miRNA roles in intestinal diseases.
  • Analysis of recent developments in electrochemical biosensor technology for miRNA detection.
  • Examination of the application of these biosensors for point-of-care diagnostics.

Main Results:

  • Abnormal miRNA expression is a hallmark of intestinal disorders.
  • Electrochemical biosensors offer rapid, sensitive, and user-friendly detection of miRNAs.
  • These biosensors show potential for integration into point-of-care settings for continuous monitoring.

Conclusions:

  • miRNA-based electrochemical biosensors represent a promising frontier for the early diagnosis and management of intestinal diseases.
  • Further advancements in biosensor technology could significantly improve patient outcomes through timely intervention.
  • This approach holds potential for personalized medicine in gastroenterology.